A Multicenter, Open-Label, Single-Arm, Phase 2 Study of ME-401 in Subjects with Follicular Lymphoma After Failure of Two or More Prior Systemic Therapies
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
MEI Pharma, Inc.
Start Date
July 10, 2020
End Date
December 12, 2023
Administered By
Duke Cancer Institute
Awarded By
MEI Pharma, Inc.
Start Date
July 10, 2020
End Date
December 12, 2023